The application of the clinical trial regulations has been postponed due to technical issues of the IT systems. Because of this, the EU Clinical Trial Regulation will not go into effect until 2019. The ultimate goal of the new system is to provide a single-entry port...
Pearl IRB proudly announces the completion of a clean FDA audit. There were no significant findings during the May 2017 audit and FDA issued no 483s. Our AAHRPP accredited IRB operates in compliance with all federal and state regulations governing clinical research....
As we enter the holiday season, please keep in mind of our operating hours. Pearl IRB will not hold a full board meeting on November 23rd but meetings will resume as scheduled the following week. The office will be open during normal business hours (8 AM – 5 PM EST)...
On Thursday, November 17th, Purdue University’s professor of Medicinal Chemistry, Dr. Stephen R Byrn, will host a free webinar exclusive for members of the Indiana Regulatory Affairs Professionals Society (RAPS) Chapter. Members may register for the webinar...
Pearl Pathways is excited to announce the hiring of Michele Taylor as a regulatory compliance analyst. Taylor will help the Pearl team serve medical device and biopharmaceutical life science companies. Taylor brings 12 years of experience in Project Management in Life...
According to the Chronicle of Higher Education, the National Academy of Sciences put together a panel of 18 members whom produced a 144-page report on university research growth as the government aims to regulate and monitor it. Some of the recommendations included...
